Song et al. developed mannosylated dual pH-responsive NPs delivering two siRNAs against vascular endothelial growth factor (VEGF) and placental growth factor (PIGF), directed towards TAMs in murine models of breast cancer. Here, VEGFA is linked to breast carcinoma.